Drug Profile
Ritipenem
Alternative Names: FCE 22101Latest Information Update: 22 Jul 2011
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antibacterials; Penems; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 22 Jul 2011 Discontinued - Phase-I for Bacterial infections in United Kingdom (IV)
- 22 Jul 2011 Discontinued - Phase-III for Bacterial infections in Italy (IV)
- 22 Jul 2011 Discontinued - Phase-III for Bacterial infections in Japan (IV)